Following youth with bipolar disorder over 12 months to track their course
Follows children and teens aged 9 to 19 with bipolar spectrum disorders over one year.
Key facts
- Who runs it
- University of California, Los Angeles
- Where
- Aurora, Los Angeles, Pittsburgh, and Richmond, United StatesSee the 4 sites
- Trial code
- Registry title
- Children's Bipolar Network Treatment Trial I
- Status
- Recruiting
- People taking part
- 80 people, planned
- Started
- 1 Jul 2022
- Expected to end
- 1 Jul 2027
- Type of study
- Observational
- Treatments tested
- Medication or psychosocial treatment
- Record updated
- 5 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for young people aged 9 to 19 who have been diagnosed with a bipolar spectrum disorder, together with a caregiver who can take part.
- Age
- 9 to 19 years
- Sex
- All sexes can join.
- Disease stage
- Bipolar disorder (type I, type II or other specified bipolar disorder) or cyclothymic disorder, diagnosed by the study team at screening.
Main reasons for not taking part
- Autism spectrum disorder diagnosis
- Substance or alcohol abuse with impairment within the last 3 months
- A medical or psychiatric disorder that is life-threatening or needs immediate hospital or emergency treatment
- Evidence of recent sexual or physical abuse of the young person by caregivers
- Evidence of recent intimate partner violence between the caregivers
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Youth 9-19 years old
- Youth diagnosed with Bipolar disorder (I, II, Other Specified) or Cyclothymic Disorder by the study team during the diagnostic interview screening
- Youth is able to read and communicate in English to the degree necessary to be able to assent and participate (with help) in their treatment and assessments appropriate for ages 9 and up
- Youth has a caregiver able to participate in ongoing basis in assessment and treatment
- The participating caregiver can reliably read and communicate in English for purposes of study consenting, assessment, and treatment, unless preferred language translation services are regularly available
Who cannot take part
- Youth has DSM-5 diagnosis of autism spectrum disorder
- Youth has DSM-5 diagnosis of substance or alcohol abuse with impairment within 3 mos
- Youth has a medical or psychiatric disorder that is life-threatening or requires immediate hospitalization or emergency medical or therapeutic treatment
- Evidence of recent sexual or physical abuse of the youth by legally responsible caregivers
- Evidence of recent intimate partner violence between caregivers responsible for the youth's care
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 9 and 19 years old?
Where in United States
- University of Colorado Anschutz Medical Campus, Helen and Arthur E. Johnson Depression CenterAurora, United StatesContact: David J Miklowitz, PhDEnrolling by invitation
- University of California, Los Angeles, Max Gray Child and Adolescent Mood Disorders Program (CHAMP)Los Angeles, United StatesContact: David J Miklowitz, PhDTaking people
- University of Pittsburgh Child and Adolescent Bipolar Spectrum Services Clinic (CABS)Pittsburgh, United StatesContact: David J Miklowitz, PhDEnrolling by invitation
- Virginia Commonwealth University Medical CenterRichmond, United StatesContact: David J Miklowitz, PhDEnrolling by invitation
About the trial
What the trial wants to find out
This is a naturalistic treatment and follow-up study of youth with bipolar spectrum disorders (BSDs) across four US sites of The Childhood Bipolar Network (CBN). CBN sites have expertise in diagnosing, assessing, and treating BSDs in youth. The primary aims of this study are to (1) identify and reliably diagnose youth (ages 9 to 19 yrs) with full bipolar disorder (BD) and BSDs, and (2) examine predictors (e.g., mood instability, inflammatory marker C-reactive protein) of clinical outcome over a 12 month period. Participating youth will initially complete a screening that includes a structured diagnostic interview and a baseline blood draw to measure inflammatory processes. Youth with BSD and parents (80 families) will be asked to participate in multiple follow up research visits with interviews, rating instruments, and questionnaires. Per established CBN guidelines, study psychiatrists will provide and track medication management and sites will also track psychosocial treatments. This study ultimately aims to further understanding of best practice pediatric BSD psychiatric and psychosocial treatments and development of a standardized and validated set of clinical tools for patient assessment, diagnosis, and tracking.
The group in the trial
- Youth with or at clinical high risk for Bipolar Spectrum Disorder
Youth included in the study will have a Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) diagnosis of Bipolar I or II, Cyclothymic Disorder, or Other Specified Bipolar Disorder (per Course and Outcome of Bipolar Youth study definition)
Treatment: Medication or psychosocial treatment
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Collaborative Treatment Network for Youth With or at High Risk for Bipolar Disorder
- Plain-language title
- Following youth with bipolar disorder over 12 months to track their courseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05427123, who can take part
- Record updated
- 5 February 2026